United States · Platforms & data · TipRanks

Cullinan Shares Updated CLN-049 Phase 1 AML/MDS Data

Published by TipRanks · United States 10 h ago

Cullinan Management ( ($CGEM) ) has provided an announcement. On November 4, 2026, Cullinan shared updated Phase 1 dose-escalation data for CLN-049 in 87 patients ...

Read the full article on TipRanks Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.tipranks.com)

Also worth reading

The Motley Fool

Sixth Street (TSLX) Q3 2026 Earnings Call Transcript

MarketBeat

IPG Photonics (NASDAQ:IPGP) Reaches New 1-Year Low Following Analyst Downgrade

MarketWatch

Hospital stocks rally while drugmakers brace for scrutiny. Here’s what the Democratic wave means for healthcare.

CNBC

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Investing.com

Curtiss-Wright stock hits 52-week low at 453.32 USD

Benzinga